Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 50 filings·Updated 7 Aug 2026
Showing 10 of 50 filings.
7 Aug 20261 filing
Company UpdateEarnings Call Transcript
Archean Chemical Q1 FY27: standalone PAT up 36% QoQ; bromine volumes guided to 20–25k t; SOP trials progressing; salt logistics headwinds easing by Q3.
Financial Performance
Standalone PAT INR405.3 million, up 36% sequentially.
Standalone EBITDA INR839 million, margin 25.3%.
Consolidated revenue INR3,328.1 million, up 10.7% YoY.
Consolidated EBITDA INR728.7 million, up 48.5% QoQ.
Consolidated PAT INR303.5 million.
Segment Update
Bromine revenue INR1,333 million, up 58% YoY; volumes 4,175 tonnes.
Industrial Salt revenue INR1,713 million; volumes 982,000 tonnes; down 12% YoY.
Bromine derivatives EBITDA positive at INR19 million; revenue up 28% YoY; 40% capacity utilisation.
Significant increase in volume has been observed in Archean Chemical Industries Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Archean Chemical Industries Limited has submitted their response.
The Exchange has sought clarification from Archean Chemical Industries Ltd on July 16, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
Filed 12:42
15 Jul 20261 filing
Company UpdateSpurt in Volume
Significant increase in volume has been observed in Archean Chemical Industries Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.